Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the company’s participation at IO Combinations 360˚ which will be held online, October 1-2, 2020. The presentation, titled “Comprehensive immunogenomics to enable composite biomarkers for immunotherapy response using a sample sparing approach,” will describe the Perso
October 1, 2020
· 3 min read